These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 8561142
21. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291 [Abstract] [Full Text] [Related]
22. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Velayos FS, Loftus EV, Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ. Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617 [Abstract] [Full Text] [Related]
23. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL. Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316 [Abstract] [Full Text] [Related]
24. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. García Rodríguez LA, Ruigómez A, Panés J. Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722 [Abstract] [Full Text] [Related]
25. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Bernstein CN, Blanchard JF, Metge C, Yogendran M. Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335 [Abstract] [Full Text] [Related]
26. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Balaguer F, Castellví-Bel S, Castells A, Andreu M, Muñoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Piqué JM, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238 [Abstract] [Full Text] [Related]
27. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Bernstein CN, Wajda A, Blanchard JF. Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423 [Abstract] [Full Text] [Related]
28. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV, EC-IBD Study Group. Digestion; 2007 Jan; 75(2-3):113-21. PubMed ID: 17598963 [Abstract] [Full Text] [Related]
30. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT. Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355 [Abstract] [Full Text] [Related]
31. Association between colorectal cancer and urologic cancers. Calderwood AH, Huo D, Rubin DT. Arch Intern Med; 2008 May 12; 168(9):1003-9. PubMed ID: 18474765 [Abstract] [Full Text] [Related]
32. Dysplasia and cancer in inflammatory bowel disease. Basseri RJ, Basseri B, Papadakis KA. Expert Rev Gastroenterol Hepatol; 2011 Feb 12; 5(1):59-66. PubMed ID: 21309672 [Abstract] [Full Text] [Related]
33. Statin use and risk of colorectal cancer. Coogan PF, Smith J, Rosenberg L. J Natl Cancer Inst; 2007 Jan 03; 99(1):32-40. PubMed ID: 17202111 [Abstract] [Full Text] [Related]
34. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Am J Gastroenterol; 2007 Jul 03; 102(7):1429-35. PubMed ID: 17437504 [Abstract] [Full Text] [Related]
35. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ, Sellers TA, Cerhan JR. Am J Gastroenterol; 2006 Aug 03; 101(8):1872-9. PubMed ID: 16790032 [Abstract] [Full Text] [Related]
36. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Ren X, Zhang X, Zhang X, Gu W, Chen K, Le Y, Lai M, Zhu Y. Public Health; 2009 Aug 03; 123(8):540-4. PubMed ID: 19664792 [Abstract] [Full Text] [Related]
37. Chemoprevention for colon cancer: new opportunities, fact or fiction? Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ. Scand J Gastroenterol Suppl; 2006 Aug 03; (243):158-64. PubMed ID: 16782636 [Abstract] [Full Text] [Related]
38. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Gastroenterology; 2008 Apr 03; 134(4):929-36. PubMed ID: 18294633 [Abstract] [Full Text] [Related]
39. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Cancer Epidemiol Biomarkers Prev; 1996 Nov 03; 5(11):897-900. PubMed ID: 8922297 [Abstract] [Full Text] [Related]
40. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Wang YR, Cangemi JR, Loftus EV, Picco MF. Am J Gastroenterol; 2013 Mar 03; 108(3):444-9. PubMed ID: 23295277 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]